Related Experiment Video

Updated: Mar 26, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.4K

Immune Monitoring Technology Primer: protein microarray ('seromics')

Jianda Yuan1, Ena Wang2, Bernard A Fox3

  • 1Immune Monitoring Core, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 386, New York, NY 10065 USA.

Journal for Immunotherapy of Cancer
|January 21, 2016
PubMed
Summary

No abstract available in PubMed .

Keywords:
Autoantibody responseBiomarkerImmune monitoringProtein microarraySeromics

More Related Videos

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

6.9K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K

Related Experiment Videos

Last Updated: Mar 26, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.4K
Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

6.9K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K

Related Concept Videos

Proteomics01:33

Proteomics

10.1K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
10.1K

Articles linked to this work by shared authors, journal, and citation graph.

Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC).

Oncoimmunology·2026

Bright side of the dark genome: antigens for next-gen cancer vaccines.

Journal for immunotherapy of cancer·2026

Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122.

Cancer medicine·2026

Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Journal for immunotherapy of cancer·2025

Multimodal AI generates virtual population for tumor microenvironment modeling.

Cell·2025

Treatment of NSCLC after chemoimmunotherapy - are we making headway?

Nature reviews. Clinical oncology·2025

AARS1-mediated lactylation reprograms macrophage lipid metabolism to restrict antitumor immunity.

Journal for immunotherapy of cancer·2026

DNA hypomethylation identifying clinical benefit subgroup of small-cell lung cancer: multi-omics analysis of a phase II trial with durvalumab plus olaparib as maintenance therapy.

Journal for immunotherapy of cancer·2026

T cells are critical for pre-metastatic niche formation through the STAT3/IL-17 axis.

Journal for immunotherapy of cancer·2026

Turning off methylglyoxal stress: an alternative approach to inhibit MDSC expansion and metastasis in triple-negative breast cancer.

Journal for immunotherapy of cancer·2026

Development of an immunocompetent cutaneous squamous cell carcinoma model identifies VISTA and CTLA-4 as targetable immune checkpoints.

Journal for immunotherapy of cancer·2026

N-glycans in non-malignant tumor microenvironment cells dampen CAR-T cell function in solid tumors.

Journal for immunotherapy of cancer·2026

Pathogenic Airway Bacteria and Local Immune Responses During Early-Life Asthma-Like Episodes.

Allergy·2026

Exploring the potential benefits of allergen immunotherapy beyond respiratory allergy.

Expert opinion on biological therapy·2026

Rituximab remodels the circulating immune landscape in pemphigus vulgaris revealed by high-dimensional immune profiling.

Journal of translational autoimmunity·2026

Bronchoalveolar Lavage Fluid α Amylase Level a Promising Biomarker of Aspiration Syndrome: A Pilot Study.

Infection and drug resistance·2026

Artificial Intelligence in Paediatric Allergy: From Diagnostic Support to Precision Medicine.

Cureus·2026

Phenotyping immune sensitization reveals pattern-based association with post-lung transplant complications.

JHLT open·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us